Seeking Alpha

More on Cepheid's (CPHD) Q4: Cites strong demand for its GeneXpert systems, despite tight...

More on Cepheid's (CPHD) Q4: Cites strong demand for its GeneXpert systems, despite tight capital in U.S. and Europe. Sets 2012 revenue guidance at $333M-$347M. Sees EPS falling in a range of $0.55 to $0.60. Shares +19.4% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)